Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma

Blood

Volumn 90, Issue 9, 1997, Pages 3482-3495

  Tarte, Karin ^a   Lu, Zhao Yang ^b   Fiol, Genevieve ^b   Legouffe, Eric ^b   Rossi, Jean François ^b   Klein, Bernard ^b  

^a CNRS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APHERESIS; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MIXED LYMPHOCYTE REACTION; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL;

EID: 1842405949     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3482     Document Type: Article

References (51)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991
2. Freudenthal PS, Steinman RM: The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87:7698, 1990
3. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747, 1996
4. + T cells. J Immunol 154:5071, 1995
5. Flamand V, Sornasse T, Thielemans K, Demanet C, Bakkus M, Bazin H, Tielemans F, Leo O, Urbain J, Moser M: Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24:605, 1994
6. Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465, 1996
7. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD: Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283, 1996
8. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphomu using autologous antigen-pulsed dendritic cells. Nature Med 2:52, 1996
9. Chevalier S, Clement C, Robledo O, Klein B, Gascan H, Wijdenes J: Monoclonal antibodies define different functional epitopes on gp130 signal transducer. Ann NY Acad Sci 762:482, 1995
10. Takahashi T, Makiguchi Y, Hinoda Y, Kakiuchi H, Nakagawa N, Imai K, Yachi A: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient. J Immunol 153:2102, 1994
11. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994
12. Reis S, Stahl PD, Austyn JM: Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178:509, 1993
13. Steinman RM, Swanson J: The endocytic activity of dendritic cells [comment]. J Exp Med 182:283, 1995
14. + T cell lines from naive precursors. Eur J Immunol 25:1206, 1995
15. + CTLs from naive precursors. J Immunol 153:996, 1994
16. + precursors. J Immunol 158:2134, 1997
17. + T cells and process soluble antigen. J Immunol 155:5427, 1995
18. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 182:1111, 1995
19. + progenitors in human bone marrow. J Immunol 149:2681, 1992
20. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony- stimulating factor, and TNF-alpha. J Immunol 154:5851, 1995
21. + blood progenitors for anticancer therapy. Exp Hematol 23:1463, 1995
22. + hematopoietic progenitor cells. Blood 87:1292, 1996
23. Mackensen A, Herbst B, Kohler G, Wolff Vorbeck G, Rosenthal FM, Veelken H, Kulmburg P, Schaefer HE, Mertelsmann R, Lindemann A: Delineation of the dendritic cell lineage by generating large numbers of Birbeck granule-positive Langerhans cells from human peripheral blood progenitor cells in vitro. Blood 86:2699, 1995
24. Caux C, Dezutter Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992
25. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184:695, 1996
26. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trocken bacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994
27. + peripheral blood monocytes. J Immunol 157:3850, 1996
28. Wijdenes J, Vooijs WC, Clement C, Post J, Morard F, Vita N, Laurent P, Sun RX, Klein B, Dore JM: A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol 94:318, 1996
29. Horvathova M, Gaillard JP, Liautard J, Duperray C, Lavabre-Bertrand T, Bourquard P, Rossi JF, Klein B, Brochier J: Identification of novel and specific antigens of human plasma cells by mAb, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leucocyte Typing V, London, UK, Oxford University Press, 1995, p 713
30. Zhang XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, Jourdan M, Boiron JM, Bataille R, Klein B: Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83:3654, 1994
31. Madsen M, Johnson HE: A methodological study of E-rosette formation using AET-treated sheep erythrocytes. J Immunol Methods 27:61, 1979
32. Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products [see comments]. J Exp Med 182:389, 1995
33. + T cells. Eur J Immunol 27:598, 1997
34. Buelens C, Verhasselt V, De Groote D, Thielemans K, Goldman M, Willems F: Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 27:756, 1997
35. Morel AS, Quaratino S, Douek DC, Londei M: Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step. Eur J Immunol 27:26, 1997
36. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny CM, Naduf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 2:1096, 1996
37. Rettig MB, Ma HJ, Vescio RA, Pold M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851, 1997
38. Neipel F, Albrecht JC, Fleckenstein B: Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity? J Virol 71:4187, 1997
39. Moore PS, Boshoff C, Weiss RA, Chang Y: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:1739, 1996
40. Santiago-Schwarz F, Divaris N, Kay C, Carsons SE: Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 10:3019, 1993
41. Sato N, Caux C, Kitamura T, Watanabe Y, Aral K, Banchereau J, Miyajima A; Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells. Blood 82:752, 1993
42. Elbaz O, Budel LM, Hoogerbrugge H, Touw IP, Delwel R, Mahmoud LA, Lowenberg B: Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood 77:989, 1991
43. Takeda K, Iwamoto S, Sugimoto H, Kawatani N, Noda M, Masaki A, Morise H, Arimura H, Konno K: Identity of differentiation inducing factor and tumour necrosis factor. Nature 323:338, 1986
44. + hematopoietic progenitor cells. Blood 87:2376, 1996
45. Henderson RA, Nimgaonkar MT, Watkins SC, Robbins PD, Ball ED, Finn OJ: Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res 56:3763, 1996
46. Alijagic S, Möller P, Artuc M, Jurgovsky K, Czarnetzki BM, Schadendorf D: Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 25:3100, 1995
47. + cytotoxic T lymphocytes. Eur J Immunol 26:2595, 1996
48. Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183:317, 1996
49. Bakkus M, Heirman C, Van Riet I, Van Camp B, Thielemans K: Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 80:2326, 1992
50. Sahota SS, Leo R, Hamblin TJ, Stevenson FK: Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood 89:219, 1997
51. Reichardt V, Okada C, Benike C, Long G, Engleman E, Blume K, Levy R: Idiotypic vaccination using dendritic cells for multiple myeloma patients after autologous peripheral blood stem cell transplantation. Blood 88:481a, 1996 (abstr, suppl 1)